Wright Medical Group, Inc. Contingent Value Right
WMGIZ
WMGIZ was delisted on the 7th of March, 2019.
25 hedge funds and large institutions have $25.7M invested in Wright Medical Group, Inc. Contingent Value Right in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
16% more capital invested
Capital invested by funds: $22.1M → $25.7M (+$3.62M)
9% more funds holding
Funds holding: 23 → 25 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$10.5M |
| 2 |
DAM
Deltec Asset Management
New York
|
+$37.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.8K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.5K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$462 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
-$8.32M |
| 2 |
6CM
683 Capital Management
New York
|
-$909K |
| 3 |
Morgan Stanley
New York
|
-$1.9K |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
-$470 |
WMGIZ Hedge Fund Activity: Q1 2017 in Review
25 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Wright Medical Group, Inc. Contingent Value Right (WMGIZ) for Q1 2017, worth a combined $25.7M — up 16% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new WMGIZ positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $10.5M. The largest seller was Newtyn Management, exiting entirely with an estimated $8.32M sold.
- 25 institutional investors held Wright Medical Group, Inc. Contingent Value Right (WMGIZ) as of Q1 2017, up from 23 in Q4 2016.
- Funds reported $25.7M of Wright Medical Group, Inc. Contingent Value Right stock for Q1 2017, up 16% quarter-over-quarter.
- 3 funds opened new Wright Medical Group, Inc. Contingent Value Right positions in Q1 2017 and 1 closed out, a net change of +2 holders.
- The largest Wright Medical Group, Inc. Contingent Value Right buyer in Q1 2017 was OrbiMed, an estimated $10.5M added.
- The largest Wright Medical Group, Inc. Contingent Value Right seller in Q1 2017 was Newtyn Management, an estimated $8.32M sold.
Based on aggregated 13F filings for Q1 2017.